S23 (Ultrabolic) 25
$86.00
Iron Ascension S23 (Ultrabolic) 25 is a high-affinity, non-steroidal Selective Androgen Receptor Modulator engineered to promote extreme lean muscle accretion, enhanced strength output, and rapid muscle hardness. Designed with an exceptionally high binding affinity to androgen receptors in skeletal muscle and bone tissue, it mimics the potent anabolic effects of traditional androgenic agents while facilitating a dry, vascular, and highly detailed physical composition.
Guaranteed safe checkout
Description
Description
Iron Ascension S23 (Ultrabolic) 25
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | S-23 (selective androgen receptor modulator candidate) |
| Concentration | 25 mg per tablet |
| Total Quantity | 60 tablets |
| Delivery System | Oral administration |
| Formulation Standard | Pharmaceutical grade — manufacturer claim, not independently verified |
| Batch Testing | High-Performance Liquid Chromatography (HPLC) |
Key Pharmacological Features
- Androgen receptor activity: S-23 is an investigational selective androgen receptor modulator (SARM) studied for its interaction with androgen receptors. Its selectivity and effects in humans are not sufficiently established to support claims of predictable muscle growth.
- Body composition: Claims of zero water retention, a consistently harder appearance, or reliable fat loss are not established clinical outcomes.
- Strength and performance: There is insufficient reliable human evidence to substantiate claims of increased strength, endurance, neuromuscular output, or training capacity.
Safety & Clinical Considerations
S-23 is an experimental compound and is not an approved medicine for bodybuilding or performance enhancement. Human safety data are limited. Potential concerns include hormonal suppression, adverse changes in cholesterol, reproductive effects, and liver-related risks. Preclinical research has also raised concerns about effects on male fertility. The long-term safety profile in humans is unknown.
Quality Control & Lab Verification
The manufacturer reports the following batch result:
| Quality Parameter | Reported Result |
|---|---|
| Compound | S-23 (oral tablets) |
| Assay Result | 99.6% active compound |
| Testing Method | HPLC — confirm against the batch-specific laboratory report |
| Verification Status | PASSED — manufacturer-reported |
Publication note: Verify the chemical identity, tablet content, 99.6% assay result, and pharmaceutical-grade designation against a genuine, batch-specific certificate of analysis. HPLC assay alone does not establish tablet uniformity, dissolution, contaminant absence, or clinical safety. S-23 remains investigational; the reported assay result should not be interpreted as evidence of human efficacy or suitability for consumption.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.